Mirum Pharmaceuticals, Inc. MIRM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accounts payable?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accounts payable of $59.4M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accounts payable increased by 410.3% year-over-year, from $11.64M to $59.4M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s accounts payable has grown at a 25.0% compound annual growth rate (CAGR), from $3.15M to $9.61M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.